The investment will make the Indianapolis facility the hub for manufacturing of Roche’s continuous glucose monitoring system.

Roche will invest $550 million in Indianapolis for a new manufacturing facility for glucose monitoring devices, adding several hundred jobs.

The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public alert on the circulation of counterfeit Accu-Chek Instant Test Strips discovered in Jos, Plateau State.